BIOSTAR PHARM-B (02563) has announced that Dr. Meng Songdong has tendered his resignation from his positions as an independent non-executive director, chairman of the remuneration and assessment committee, and member of the audit committee, effective April 29, 2026, due to requirements from his primary employer. The board of directors has resolved to propose the appointment of Dr. Zhu Xiaodong as an independent non-executive director for the second board of directors. His term will conclude at the end of the second board's tenure, pending approval by shareholders through relevant resolutions at the company's annual general meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments